Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy

S Chakrabarti1, M Cukiernik, D Hileeto

  • 1Department of Pathology, University of Western Ontario, London, Ontario, Canada. schakrab@julian.uwo.ca

Insights

Sustained hyperglycemia in diabetes activates biochemical pathways, influencing vasoactive factors and causing retinal changes. Understanding these interactions is key for developing new diabetic retinopathy treatments.

Area of Science:

  • Biochemistry
  • Ophthalmology
  • Diabetology

Background:

  • Sustained hyperglycemia in diabetes mellitus can activate several abnormal biochemical pathways.
  • These pathways include protein kinase C (PKC) activation, augmented polyol pathway flux, and non-enzymatic glycation.
  • These biochemical changes are implicated in the development of diabetic retinopathy.

Purpose of the Study:

  • To explore the biochemical pathways involved in diabetic retinopathy.
  • To investigate the role of vasoactive factors in mediating retinal changes in diabetes.
  • To understand the interactive mechanisms among these factors for potential therapeutic development.

Main Methods:

  • The study reviews existing literature on biochemical pathways and vasoactive factors in diabetic retinopathy.
  • It focuses on the interplay between hyperglycemia, biochemical abnormalities, and vasoactive mediators.
  • Mechanisms influencing functional and morphological retinal changes are discussed.

Main Results:

  • Hyperglycemia triggers interconnected biochemical pathways (PKC, polyol, glycation).
  • These pathways influence vasoactive factors like endothelins, nitric oxide, and vascular endothelial growth factors.
  • These factors are critical in causing structural and functional alterations in early diabetic retinopathy.

Conclusions:

  • Abnormal biochemical pathways and vasoactive factors are central to diabetic retinopathy pathogenesis.
  • Complex regulatory interactions among these factors determine their biological effects.
  • Further understanding of these mechanisms can guide the development of adjuvant therapies for diabetic retinopathy.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.